Malaria por Plasmodium vivax y falla al tratamiento radical
García, Julián; Seijo, Agustín; Benchetrit, Andrés; Couto, Esteban; Echazarreta, Sofía; Lloveras, Susana; Orduna, Tomás.
Rev. chil. infectol
; 33(4): 468-471, ago. 2016.
Artículo en Español | LILACS | ID: biblio-830117
Documentos relacionados
Comparison of lumefantrine, mefloquine, and piperaquine concentrations between capillary plasma and venous plasma samples in pregnant women with uncomplicated falciparum and vivax malaria.
[Failure to radical cure in Plasmodium vivax malaria].
Efficacy of three anti-malarial regimens for uncomplicated Plasmodium falciparum malaria in Cambodia, 2009-2011: a randomized controlled trial and brief review.
Severe vivax malaria: a case report and a literature review.
Efficacy of Artesunate-mefloquine for Chloroquine-resistant Plasmodium vivax Malaria in Malaysia: An Open-label, Randomized, Controlled Trial.
Imported malaria in a non-endemic area: the experience of the university of Campinas hospital in the Brazilian Southeast.
Monitoring antimalarial drug efficacy in the Greater Mekong Subregion: an overview of in vivo results from 2008 to 2010.
Impact of the first-line treatment shift from dihydroartemisinin/piperaquine to artesunate/mefloquine on Plasmodium vivax drug susceptibility in Cambodia.
Atovaquone-proguanil for treating uncomplicated Plasmodium falciparum malaria.
Prevalence and characterization of piperaquine, mefloquine and artemisinin derivatives triple-resistant Plasmodium falciparum in Cambodia.